Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer

BACKGROUND: The incidence of oesophageal adenocarcinoma is increasing worldwide but survival remains poor. Neoadjuvant chemotherapy can improve survival, but prognostic and predictive biomarkers are required. This study built upon preclinical approaches to identify prognostic plasma proteomic marker...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, P, Paulin, F, Lamont, D, Baker, L, Clearly, S, Exon, D, Thompson, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305965/
https://www.ncbi.nlm.nih.gov/pubmed/22294182
http://dx.doi.org/10.1038/bjc.2012.15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305965/
https://www.ncbi.nlm.nih.gov/pubmed/22294182
http://dx.doi.org/10.1038/bjc.2012.15

Ejemplares similares